Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan.

Trial Profile

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2012

At a glance

  • Drugs Imidafenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 05 Nov 2010 New trial record.
    • 06 Apr 2006 Planned patient number is 750 according to ClinicalTrials.gov.
    • 06 Apr 2006 Company (Ono Pharmaceutical) added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top